>
White House Correspondents' Dinner Shooter's Link to NASA and Other Curiosities
US Military Ends 72-Year Mandatory Flu Shot Policy
3 Million Ounces of Gold and 28 Million Ounces of Silver Taken Out the Back Door
Researcher wins 1 bitcoin bounty for 'largest quantum attack' on underlying tech
Interceptor-Drone Arms-Race Emerges
A startup called Inversion has introduced Arc, a space-based vehicle...
Mining companies are using cosmic rays to find critical minerals
They regrew a severed nerve - by shortening a bone.
New Robot Ants Work Like Real Insects To Build And Dismantle On Their Own
Russian scientists 'are developing the world's first drug to delay ageing' months after
Sam Altman's World ID Expands Biometric Identity Checks
China Tests Directed Energy Beam That Recharges Drones Mid-Flight
Jurassic Park might arrive sooner than expected, just with Dinobots.

There is fastly progressing science and there is a rapid increase in funding and formation of companies. Areas that were making slow progress like Mitosens are now rapidly progressing. Cross-linking is making progress as well.
Robust mouse rejuvenation could be only 3 years away instead of five years. Robust mouse rejuvenation could be by 2022.
Aubrey is more optimistic that partial SENS will be able to deliver significant life extension impact.
Aubrey sees a lot of activity in all seven areas of aging damage identified by SENS.
It seems that the removal of senescent cells will deliver useful health benefits and some longevity.
Aubrey indicates that SENS has a fantastic relationship with the Buck Institute. SENS has multiple projects.
Aubrey is working at AgeX as a Vice-president. Previously Aubrey had believed that there was not much need for SENS to fund stem cell research. Aubrey always considered stem cells to be important. Michael West is doing some of the most important work on stem cells.